$NRIX 4 SEC Filings

Filed On	Filing
15 Oct 2026	Form 4: Hansen Gwenn, Chief Scientific Officer Received 1,452 shares by exercise or conversion ($2.7K) · Sold 1,452 shares ($36.3K)
14 Oct 2026	Form 4: Gregory Julia P, Director Received 22,583 shares by exercise or conversion ($42K) · Sold 22,583 shares ($529K)
02 Oct 2026	Form 4: Ring Christine, Chief Legal Officer Received 5,786 shares by exercise or conversion ($50.5K) · Sold 5,786 shares ($134K)
02 Sep 2026	Form 4: Ring Christine, Chief Legal Officer Received 5,787 shares by exercise or conversion ($50.5K) · Sold 5,787 shares ($149K)
01 Sep 2026	Form 4: Hansen Gwenn, Chief Scientific Officer Received 1,452 shares by exercise or conversion ($2.7K) · Sold 1,452 shares ($37K)
05 Aug 2026	Form 4: Hansen Gwenn, Chief Scientific Officer Received 4,356 shares by exercise or conversion ($8.1K) · Sold 4,356 shares ($109K)
05 Aug 2026	Form 4: Hansen Gwenn, Chief Scientific Officer Sold 4,111 shares ($100K)
04 Aug 2026	Form 4: van Houte Hans, Chief Financial Officer Sold 4,761 shares ($116K)
03 Aug 2026	Form 4: Ring Christine, Chief Legal Officer Received 5,787 shares by exercise or conversion ($50.5K) · Sold 16,589 shares ($382K)
30 Jul 2026	Form 4: van Houte Hans, Chief Financial Officer Received 10,180 shares by exercise or conversion · Sold 2,845 shares ($66.5K)
30 Jul 2026	Form 4: Ring Christine, Chief Legal Officer Received 10,180 shares by exercise or conversion · Sold 3,847 shares ($90K)
30 Jul 2026	Form 4: Hansen Gwenn, Chief Scientific Officer Received 10,180 shares by exercise or conversion · Sold 3,847 shares ($90K)
02 Jul 2026	Form 4: Ring Christine, Chief Legal Officer Received 11,008 shares by exercise or conversion ($60.2K) · Sold 11,008 shares ($259K)
25 Jun 2026	Form 4: Ring Christine, Chief Legal Officer Received 28,935 shares by exercise or conversion ($233K) · Sold 28,935 shares ($581K)
25 Jun 2026	Form 4: Hansen Gwenn, Chief Scientific Officer Sold 5,394 shares ($108K)
02 Jun 2026	Form 4: Ring Christine, Chief Legal Officer Received 3,422 shares by exercise or conversion ($6.36K) · Sold 8,148 shares ($135K)
15 May 2026	Form 4: Silva Paul M, Director Granted 31,250 Director Stock Option (right to buy)
15 May 2026	Form 4: Saltzman Edward C, Director Granted 31,250 Director Stock Option (right to buy)
15 May 2026	Form 4: Reinsdorf Judith A, Director Granted 31,250 Director Stock Option (right to buy)
15 May 2026	Form 4: Lacey David L., Director Granted 31,250 Director Stock Option (right to buy)

Comments